A Portable Thoracic Impedance Device for Detecting Pulmonary Congestion in Heart Failure Patients

NCT06604468 · tracked via the Priya Life Science Canada tracker

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Phase

Observational

Started

2025-09-01

Last updated

2025-10-06

Condition(s) studied

Heart Failure

Investigational drug(s) / intervention(s)

Thoracic bioimpedance tomography

Thoracic bioimpedance tomography: Data collection using a thoracic bioimpedance tomography device

Study summary

This study investigates a portable thoracic bioimpedance tomography (TBIT) device designed to detect early lung congestion in heart failure patients. The main goal is to evaluate how well the device's measurements match those obtained from lung ultrasound and other imaging techniques. By detecting lung fluid build-up before symptoms worsen, this device could help manage heart failure more effectively outside of hospital settings, potentially improving patient care and reducing hospital admissions. Participants in the study are monitored using this device along with standard imaging methods, and data on heart failure symptoms are collected to understand the device\'s accuracy and usability.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Adults aged 18 years or older. * Diagnosed with heart failure, defined by the following criterion: hospitalization or an emergency visit for decompensated heart failure (pulmonary edema) within the last 12 months. Exclusion Criteria: * Pregnant women at the time of eligibility evaluation. * Presence of an implanted electronic device in the thorax, such as a pacemaker or defibrillator. * Inability to provide informed consent. * Admission to intensive care or the coronary care unit.

Primary outcome measure(s)

Lung congestion — Baseline, week 4, week 8
Assessed using lung ultrasound over 12 thoracic zones to calculate the B-line score

Trial sites (1)

Facility	City	Region	Status
CHUM	Montreal	Quebec	Recruiting

More Centre hospitalier de l'Université de Montréal (CHUM) trials in Canada

Safety of PET MPI Using the CRCHUM N-13 Ammonia Recruiting

Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface Recruiting

Minimally Invasive Three-dimensional Knee Kinematic Assessment and Surgical Guidance Using Ultrasonic Rigid Registration Starting soon

Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot Study Starting soon

Adaptive RadioTherapy for OroPharynx Cancer Recruiting

Other trials for the same condition

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients Recruiting

Exploratory Study of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW Canada) Active, not recruiting

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease Recruiting

Oral Carnitine in Heart Failure Patients Recruiting

Surgical Ablation of AF Efficacy Trial Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06604468 on ClinicalTrials.gov ↗ ← All trials in Canada